Skip to main content

Table 1 Demographic and clinical characteristics

From: Cognitive behavioral group treatment for low self-esteem in psychosis: a proof of concept study

 

Participants

n

30

Age mean (SD)

32.5 (9.5)

Gender male n (%)

15 (50.0%)

DSM diagnosisa

 Schizophrenia

9 (31.0%)

 Schizoaffective disorder

7 (24.1%)

 Delusional disorder

1 (3.4%)

 Psychotic disorder not otherwise specified

12 (41.4%)

Comorbid diagnosisa

 Depressive disorder

5 (17.2%)

 Substance use disorder

4 (13.8%)

 Borderline personality disorder

2 (6.8%)

 Dependent personality disorder

2 (6.8%)

 Autism spectrum disorder

1 (3.4%)

 None

18 (62.0%)

Medication usea

 Antipsychotics

29 (100%)

 Aripiprazole

10 (34.5%)

 Cisordinole

1 (3.4%)

 Clozapine

6 (20.7)

 Haloperidole

1 (3.4%)

 Olanzapine

6 (20.7%)

 Pimozide

1 (3.4%)

 Quetiapine

8 (27.5%)

 Risperidone

9 (31.0%)

 Olanzapine equivalent of prescribed antipsychotic medication (mean, mg per day)

9.9 (5.0)

 Antidepressants

8 (27.6%)

 Citalopram

2 (6.8%)

 Clomipramine

1 (3.4%)

 Mirtazepine

1 (3.4%)

 Nortryptiline

2 (6.8%)

 Venlafaxine

2 (6.8%)

 Outpatient a

26 (89.7%)

Completed education a

 Primary education

0 (0%)

 Secondary education

10 (34.5%)

 Vocational education

8 (27.6%)

 Higher

11 (38.0%)

Employment status a

 Paid work

9 (31.0%)

 Volunteer work

7 (24.1%)

 Unemployed

7 (24.1%)

 Study

6 (20.7%)

Relationship status a

 Relationship

6 (20.7%)

 Single

23 (79.3%)

  1. aFor these characteristics, data of 29 instead of 30 patients could be obtained
  2. Data are n (%) or mean (SD).